The research conducted by Lau et al. [156] revealed that hepatocyte growth factor (HGF) derived from cancer-associated fibroblasts (CAFs) regulates liver tumor-initiating cells by activating FRA1 through an Erk1,2-dependent pathway. The gene discussed is HGF; the disease is cancer.